[{"id":"3ede8ad2-acee-4e50-a570-83fc9035aab8","acronym":"","url":"https://clinicaltrials.gov/study/NCT01782313","created_at":"2021-01-18T07:51:26.424Z","updated_at":"2024-07-02T16:36:55.886Z","phase":"Phase 2","brief_title":"A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas","source_id_and_acronym":"NCT01782313","lead_sponsor":"Northwestern University","biomarkers":" KDR • FLT1","pipe":" | ","alterations":" KDR expression • FLT1 expression","tags":["KDR • FLT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KDR expression • FLT1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Fotivda (tivozanib)"],"overall_status":"Completed","enrollment":" Enrollment 58","initiation":"Initiation: 03/06/2013","start_date":" 03/06/2013","primary_txt":" Primary completion: 05/27/2015","primary_completion_date":" 05/27/2015","study_txt":" Completion: 12/28/2016","study_completion_date":" 12/28/2016","last_update_posted":"2019-09-09"}]